TauRx Pharmaceuticals
Dr Harrington has extensive research experience in the field of neurodegenerative diseases and is author of more than 50 publications and co-inventor in 12 patent applications in this area. He has collaborated with Professor Wischik for over 30 years, developing assays for screening agents having the potential to prevent the tau pathology that is the hallmark of Alzheimer’s disease.
This person is not in the org chart
This person is not in any offices
TauRx Pharmaceuticals
TauRx is leader in Alzheimer’s disease research. Their mission is to discover, develop and commercialise innovative products for the diagnosis, treatment.